Healthcare Analytics Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Hardware, Software, Service (Software Service, & Business Analytics Service)), By Deployment Mode (On-Premises, Cloud), By Type (Predictive Analytics, Prescriptive Analytics, Descriptive Analytics), By Application (Financial Analysis, Operational & Administrative Analysis, Clinical Analysis, Population Health Analysis), By End User (Healthcare Payers, Healthcare Providers, Life Science Companies), By Region & Competition, 2021-2031F
The Global Healthcare Analytics Market is projected to experience substantial growth, rising from USD 49.33 Billion in 2025 to USD 194.96 Billion by 2031, representing a CAGR of 25.74%. This market involves the systematic use of computational analysis, statistical modeling, and data aggregation to extract actionable insights that drive improvements in operational, financial, and clinical areas. Key factors fueling this expansion include the urgent need to reduce rising healthcare costs and the industry-wide shift toward value-based care models, which require accurate measurement of patient outcomes. Additionally, the extensive digitization of medical records creates the foundational infrastructure needed to implement robust analytical tools that refine provider decision-making and optimize resource allocation.
Despite this progress, significant hurdles regarding data interoperability and strict privacy regulations continue to obstruct the smooth exchange of sensitive information across different systems. However, adoption rates for advanced data tools are accelerating among providers aiming to utilize technology for greater clinical and administrative efficiency. According to the American Medical Association in 2024, 66% of physicians reported currently using artificial intelligence tools in their practice, a notable increase from 38% the previous year. This statistic highlights the rapid incorporation of sophisticated analytical capabilities within the healthcare sector.
Market Driver
The convergence of Artificial Intelligence (AI) and Big Data acts as a major catalyst for the Global Healthcare Analytics Market, fundamentally transforming how providers handle operational efficiency and clinical decision support. By utilizing complex datasets, healthcare institutions can now employ predictive modeling to forecast patient outcomes and allocate resources with high precision. This technological evolution is swiftly moving from theoretical pilots to practical application, driven by the necessity to manage growing volumes of data. According to the Medical Group Management Association (MGMA) in an October 2024 poll, 43% of medical groups reported adding or expanding their use of AI this year, demonstrating a tangible industry shift toward automated intelligence for handling complex medical information.
At the same time, the growth of cloud-based analytics solutions is providing the essential infrastructure needed to support these advanced capabilities. Legacy on-premise systems are increasingly being replaced by agile cloud platforms that facilitate seamless interoperability and data exchange, which are vital for population health management. Leadership teams are prioritizing this modernization to ensure their data systems are robust enough for future analytics needs. According to Hakkoda?s 'Healthcare State of Data 2024' report from March 2024, 74% of healthcare organizations intend to centralize on a cloud platform within the next two years, indicating a significant structural migration. This momentum is further supported by sustained capital investment; according to Rock Health, U.S. digital health startups raised $5.7 billion across 266 deals in the first half of 2024 alone, highlighting the market's financial strength.
Market Challenge
A primary obstacle to the expansion of the Global Healthcare Analytics Market is the persistent lack of data interoperability combined with rigorous privacy regulations. Although the sector produces vast amounts of health information, this data often remains isolated in fragmented silos due to proprietary standards and incompatible software systems. For analytics to provide accurate predictive modeling and actionable insights, algorithms must have access to comprehensive, longitudinal patient records. When data cannot flow seamlessly between disparate financial and clinical systems, the resulting datasets are frequent incomplete or inconsistent, which undermines the reliability of analytical outputs and reduces provider confidence in data-driven strategies.
Moreover, the operational resources needed to navigate these complex compliance landscapes and bridge technical gaps significantly deplete organizational budgets. Instead of investing in advanced analytical capabilities, healthcare entities are often forced to divert capital toward regulatory adherence and manual data reconciliation. This administrative burden is substantial; according to the Medical Group Management Association in 2024, 89% of medical practice leaders reported that the overall regulatory burden on their practice had increased over the past 12 months. This rise in non-clinical workload directly limits the financial resources available for adopting robust analytics solutions, effectively slowing market growth.
Market Trends
The growth of Real-World Evidence (RWE) analytics in life sciences is reshaping regulatory pathways and drug development. Pharmaceutical companies are increasingly using analytics to process data from patient registries and electronic health records to supplement clinical trials. This trend enables faster validation of drug efficacy and accelerates post-market surveillance by analyzing diverse populations outside of controlled environments. The scale of this data integration is massive and crucial for supporting regulatory decisions. According to the European Medicines Agency's 'Data Analysis and Real-World Interrogation Network (DARWIN EU)' report from March 2024, the network expanded its capacity to deliver real-world evidence by accessing data from approximately 130 million patients across Europe, enabling stakeholders to generate robust evidence on medicine effectiveness in real-time settings.
Furthermore, the convergence of remote monitoring data streams and wearable IoT is driving demand for analytics capable of processing high-frequency patient-generated health data. Healthcare providers are shifting from episodic care to continuous monitoring, necessitating algorithms that can interpret physiological data to detect early warning signs. This integration empowers clinicians to intervene proactively, thereby reducing hospital readmissions and improving long-term patient outcomes. Investment in these monitoring capabilities is accelerating as organizations recognize the value of predictive care. According to the Royal Philips 'Future Health Index 2024' report from June 2024, 40% of healthcare leaders indicated plans to expand remote patient monitoring into telestroke care within the next three years, highlighting the critical role of predictive analytics in modernizing patient care delivery.
Key Market Players
In this report, the Global Healthcare Analytics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Healthcare Analytics Market.
Available Customizations:
Global Healthcare Analytics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Despite this progress, significant hurdles regarding data interoperability and strict privacy regulations continue to obstruct the smooth exchange of sensitive information across different systems. However, adoption rates for advanced data tools are accelerating among providers aiming to utilize technology for greater clinical and administrative efficiency. According to the American Medical Association in 2024, 66% of physicians reported currently using artificial intelligence tools in their practice, a notable increase from 38% the previous year. This statistic highlights the rapid incorporation of sophisticated analytical capabilities within the healthcare sector.
Market Driver
The convergence of Artificial Intelligence (AI) and Big Data acts as a major catalyst for the Global Healthcare Analytics Market, fundamentally transforming how providers handle operational efficiency and clinical decision support. By utilizing complex datasets, healthcare institutions can now employ predictive modeling to forecast patient outcomes and allocate resources with high precision. This technological evolution is swiftly moving from theoretical pilots to practical application, driven by the necessity to manage growing volumes of data. According to the Medical Group Management Association (MGMA) in an October 2024 poll, 43% of medical groups reported adding or expanding their use of AI this year, demonstrating a tangible industry shift toward automated intelligence for handling complex medical information.
At the same time, the growth of cloud-based analytics solutions is providing the essential infrastructure needed to support these advanced capabilities. Legacy on-premise systems are increasingly being replaced by agile cloud platforms that facilitate seamless interoperability and data exchange, which are vital for population health management. Leadership teams are prioritizing this modernization to ensure their data systems are robust enough for future analytics needs. According to Hakkoda?s 'Healthcare State of Data 2024' report from March 2024, 74% of healthcare organizations intend to centralize on a cloud platform within the next two years, indicating a significant structural migration. This momentum is further supported by sustained capital investment; according to Rock Health, U.S. digital health startups raised $5.7 billion across 266 deals in the first half of 2024 alone, highlighting the market's financial strength.
Market Challenge
A primary obstacle to the expansion of the Global Healthcare Analytics Market is the persistent lack of data interoperability combined with rigorous privacy regulations. Although the sector produces vast amounts of health information, this data often remains isolated in fragmented silos due to proprietary standards and incompatible software systems. For analytics to provide accurate predictive modeling and actionable insights, algorithms must have access to comprehensive, longitudinal patient records. When data cannot flow seamlessly between disparate financial and clinical systems, the resulting datasets are frequent incomplete or inconsistent, which undermines the reliability of analytical outputs and reduces provider confidence in data-driven strategies.
Moreover, the operational resources needed to navigate these complex compliance landscapes and bridge technical gaps significantly deplete organizational budgets. Instead of investing in advanced analytical capabilities, healthcare entities are often forced to divert capital toward regulatory adherence and manual data reconciliation. This administrative burden is substantial; according to the Medical Group Management Association in 2024, 89% of medical practice leaders reported that the overall regulatory burden on their practice had increased over the past 12 months. This rise in non-clinical workload directly limits the financial resources available for adopting robust analytics solutions, effectively slowing market growth.
Market Trends
The growth of Real-World Evidence (RWE) analytics in life sciences is reshaping regulatory pathways and drug development. Pharmaceutical companies are increasingly using analytics to process data from patient registries and electronic health records to supplement clinical trials. This trend enables faster validation of drug efficacy and accelerates post-market surveillance by analyzing diverse populations outside of controlled environments. The scale of this data integration is massive and crucial for supporting regulatory decisions. According to the European Medicines Agency's 'Data Analysis and Real-World Interrogation Network (DARWIN EU)' report from March 2024, the network expanded its capacity to deliver real-world evidence by accessing data from approximately 130 million patients across Europe, enabling stakeholders to generate robust evidence on medicine effectiveness in real-time settings.
Furthermore, the convergence of remote monitoring data streams and wearable IoT is driving demand for analytics capable of processing high-frequency patient-generated health data. Healthcare providers are shifting from episodic care to continuous monitoring, necessitating algorithms that can interpret physiological data to detect early warning signs. This integration empowers clinicians to intervene proactively, thereby reducing hospital readmissions and improving long-term patient outcomes. Investment in these monitoring capabilities is accelerating as organizations recognize the value of predictive care. According to the Royal Philips 'Future Health Index 2024' report from June 2024, 40% of healthcare leaders indicated plans to expand remote patient monitoring into telestroke care within the next three years, highlighting the critical role of predictive analytics in modernizing patient care delivery.
Key Market Players
- Digital Reasoning Systems Inc.
- International Business Machines Corporation (IBM)
- Information Builders Inc.
- Allscripts Healthcare Solutions, Inc.
- IQVIA Holdings Inc.
- 3M Company
- McKesson Corporation
- MedeAnalytics Inc.
- Optum Inc.
- Cerner Corporation
In this report, the Global Healthcare Analytics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Healthcare Analytics Market, By Component
- Hardware
- Software
- Service (Software Service
- & Business Analytics Service)
- Healthcare Analytics Market, By Deployment Mode
- On-Premises
- Cloud
- Healthcare Analytics Market, By Type
- Predictive Analytics
- Prescriptive Analytics
- Descriptive Analytics
- Healthcare Analytics Market, By Application
- Financial Analysis
- Operational & Administrative Analysis
- Clinical Analysis
- Population Health Analysis
- Healthcare Analytics Market, By End User
- Healthcare Payers
- Healthcare Providers
- Life Science Companies
- Healthcare Analytics Market, By Region
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Healthcare Analytics Market.
Available Customizations:
Global Healthcare Analytics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL HEALTHCARE ANALYTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Hardware, Software, Service (Software Service, & Business Analytics Service))
5.2.2. By Deployment Mode (On-Premises, Cloud)
5.2.3. By Type (Predictive Analytics, Prescriptive Analytics, Descriptive Analytics)
5.2.4. By Application (Financial Analysis, Operational & Administrative Analysis, Clinical Analysis, Population Health Analysis)
5.2.5. By End User (Healthcare Payers, Healthcare Providers, Life Science Companies)
5.2.6. By Region
5.2.7. By Company (2025)
5.3. Market Map
6. NORTH AMERICA HEALTHCARE ANALYTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Deployment Mode
6.2.3. By Type
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Healthcare Analytics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Component
6.3.1.2.2. By Deployment Mode
6.3.1.2.3. By Type
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Healthcare Analytics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Component
6.3.2.2.2. By Deployment Mode
6.3.2.2.3. By Type
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Healthcare Analytics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Component
6.3.3.2.2. By Deployment Mode
6.3.3.2.3. By Type
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. EUROPE HEALTHCARE ANALYTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Deployment Mode
7.2.3. By Type
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Healthcare Analytics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Component
7.3.1.2.2. By Deployment Mode
7.3.1.2.3. By Type
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. France Healthcare Analytics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Component
7.3.2.2.2. By Deployment Mode
7.3.2.2.3. By Type
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Healthcare Analytics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Component
7.3.3.2.2. By Deployment Mode
7.3.3.2.3. By Type
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Healthcare Analytics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Component
7.3.4.2.2. By Deployment Mode
7.3.4.2.3. By Type
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Healthcare Analytics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Component
7.3.5.2.2. By Deployment Mode
7.3.5.2.3. By Type
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. ASIA PACIFIC HEALTHCARE ANALYTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Deployment Mode
8.2.3. By Type
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Healthcare Analytics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Deployment Mode
8.3.1.2.3. By Type
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Healthcare Analytics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Deployment Mode
8.3.2.2.3. By Type
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Healthcare Analytics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Deployment Mode
8.3.3.2.3. By Type
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Healthcare Analytics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Component
8.3.4.2.2. By Deployment Mode
8.3.4.2.3. By Type
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Healthcare Analytics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Component
8.3.5.2.2. By Deployment Mode
8.3.5.2.3. By Type
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component
9.2.2. By Deployment Mode
9.2.3. By Type
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Healthcare Analytics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Deployment Mode
9.3.1.2.3. By Type
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. UAE Healthcare Analytics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Deployment Mode
9.3.2.2.3. By Type
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. South Africa Healthcare Analytics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Deployment Mode
9.3.3.2.3. By Type
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. SOUTH AMERICA HEALTHCARE ANALYTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component
10.2.2. By Deployment Mode
10.2.3. By Type
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Healthcare Analytics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Deployment Mode
10.3.1.2.3. By Type
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Colombia Healthcare Analytics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Deployment Mode
10.3.2.2.3. By Type
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Argentina Healthcare Analytics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Deployment Mode
10.3.3.2.3. By Type
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL HEALTHCARE ANALYTICS MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Digital Reasoning Systems Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. International Business Machines Corporation (IBM)
15.3. Information Builders Inc.
15.4. Allscripts Healthcare Solutions, Inc.
15.5. IQVIA Holdings Inc.
15.6. 3M Company
15.7. McKesson Corporation
15.8. MedeAnalytics Inc.
15.9. Optum Inc.
15.10. Cerner Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL HEALTHCARE ANALYTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Hardware, Software, Service (Software Service, & Business Analytics Service))
5.2.2. By Deployment Mode (On-Premises, Cloud)
5.2.3. By Type (Predictive Analytics, Prescriptive Analytics, Descriptive Analytics)
5.2.4. By Application (Financial Analysis, Operational & Administrative Analysis, Clinical Analysis, Population Health Analysis)
5.2.5. By End User (Healthcare Payers, Healthcare Providers, Life Science Companies)
5.2.6. By Region
5.2.7. By Company (2025)
5.3. Market Map
6. NORTH AMERICA HEALTHCARE ANALYTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Deployment Mode
6.2.3. By Type
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Healthcare Analytics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Component
6.3.1.2.2. By Deployment Mode
6.3.1.2.3. By Type
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Healthcare Analytics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Component
6.3.2.2.2. By Deployment Mode
6.3.2.2.3. By Type
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Healthcare Analytics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Component
6.3.3.2.2. By Deployment Mode
6.3.3.2.3. By Type
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. EUROPE HEALTHCARE ANALYTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Deployment Mode
7.2.3. By Type
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Healthcare Analytics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Component
7.3.1.2.2. By Deployment Mode
7.3.1.2.3. By Type
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. France Healthcare Analytics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Component
7.3.2.2.2. By Deployment Mode
7.3.2.2.3. By Type
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Healthcare Analytics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Component
7.3.3.2.2. By Deployment Mode
7.3.3.2.3. By Type
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Healthcare Analytics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Component
7.3.4.2.2. By Deployment Mode
7.3.4.2.3. By Type
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Healthcare Analytics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Component
7.3.5.2.2. By Deployment Mode
7.3.5.2.3. By Type
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. ASIA PACIFIC HEALTHCARE ANALYTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Deployment Mode
8.2.3. By Type
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Healthcare Analytics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Deployment Mode
8.3.1.2.3. By Type
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Healthcare Analytics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Deployment Mode
8.3.2.2.3. By Type
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Healthcare Analytics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Deployment Mode
8.3.3.2.3. By Type
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Healthcare Analytics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Component
8.3.4.2.2. By Deployment Mode
8.3.4.2.3. By Type
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Healthcare Analytics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Component
8.3.5.2.2. By Deployment Mode
8.3.5.2.3. By Type
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component
9.2.2. By Deployment Mode
9.2.3. By Type
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Healthcare Analytics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Deployment Mode
9.3.1.2.3. By Type
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. UAE Healthcare Analytics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Deployment Mode
9.3.2.2.3. By Type
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. South Africa Healthcare Analytics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Deployment Mode
9.3.3.2.3. By Type
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. SOUTH AMERICA HEALTHCARE ANALYTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component
10.2.2. By Deployment Mode
10.2.3. By Type
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Healthcare Analytics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Deployment Mode
10.3.1.2.3. By Type
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Colombia Healthcare Analytics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Deployment Mode
10.3.2.2.3. By Type
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Argentina Healthcare Analytics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Deployment Mode
10.3.3.2.3. By Type
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL HEALTHCARE ANALYTICS MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Digital Reasoning Systems Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. International Business Machines Corporation (IBM)
15.3. Information Builders Inc.
15.4. Allscripts Healthcare Solutions, Inc.
15.5. IQVIA Holdings Inc.
15.6. 3M Company
15.7. McKesson Corporation
15.8. MedeAnalytics Inc.
15.9. Optum Inc.
15.10. Cerner Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
